Price (delayed)
$1.27
Market cap
$378.27M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.13
Enterprise value
$994.65M
Pacific Biosciences of California, Inc. is empowering life scientists with highly accurate long-read sequencing. The company's innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a
There are no recent dividends present for PACB.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.